Because cancer patients are individuals

2cureX - Individualizing Cancer Treatment

2cureX is about improving cancer treatment with the individual patient in focus

By testing the patient’s cancer cells for their sensitivity against approved anti-cancer drugs, IndiTreat® helps the oncologist in selecting the most effective treatment for the individual cancer patient.

IndiTreat® does not predict; but measures the treatment effectiveness and resistance for the individual cancer patient. The right individual cancer treatment saves the patient from unnecessary side effects and provides cost efficiency in drug-spending.


To establish IndiTreat® as the global standard for measuring an individual cancer patient’s response to different drug therapy options.


To make a real difference for individual cancer patients around the world by matching the most optimal therapy with the individual treatment needs.

Contact information

2cureX, Fruebjergvej 3, 2100 Copenhagen Ø, Denmark| Phone: +45 2211 5399| E-mail:

This project has received funding from the European Union’s Horizon 2020 SME-Instrument program under grant agreement No 777718.

Privacy Policy | Imprint